Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent - Concepedia

Concepedia

Publication | Open Access

Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent

DOI Full Paper Access

91

Citations

34

References

2014

Year

Francesca Del Bufalo, Andrea Carai, Lorenzo Figà-Talamanca, Benedetta Pettorini, Conor Mallucci, Felice Giangaspero, Manila Antonelli, Manuela Badiali, Loredana Moi, Giuseppe Bianco,

Journal of Translational Medicine

Abstract

Our experience underline the importance of understanding the driver molecular alterations of LGG and suggests a role for Vemurafenib in the treatment of pediatric GG not amenable of complete surgical resection.

References

	Year	Citations

Page 1